The Vitamin D Receptor (VDR) Gene Polymorphisms in Turkish Brain Cancer Patients

Table 3

The risk of meningioma and glioma associated with VDR genotypes.

SNP	Controls	Meningioma	OR (95% CI)	𝑃 value	Glioma	OR (95% CI)	𝑃 value
Fok-1
FF	56 (45.9%)	19 (43.2%)	1.050 (0.774–1.425)	0.756	28 (50%)	1.089 (0.787–1.508)	0.611
Ff + ff	66 (54.1%)	25 (56.8%)			28 (50)
FF + Ff	119 (97.5%)	37 (84.1%)	6.470 (1.749–23.926)	0.001	51 (91.1%)	3.631 (0.899–14.665)	0.053
ff	3 (2.5%)	7 (15.9%)			5 (8.9%)
Taq-I
TT	65 (53.3%)	23 (52.3%)	1.022 (0.711–1.468)	0.909	32 (57.1%)	1.073 (0.810–1.421)	0.631
Tt + tt	57 (46.7%)	2 (47.7%)			24 (42.9%)
TT + Tt	109 (89.3%)	41 (93.2%)	1.043 (0.943–1.153)	0.460	50 (89.3%)	1.005 (0.403–2.508)	0.991
tt	13 (10.7%)	3 (6.8%)			6 (10.7%)